Revance Therapeutics RVNC
$ 3.09
0.49%
Quarterly report 2024-Q3
added 11-07-2024
Revance Therapeutics Financial Statements 2011-2024 | RVNC
Annual Financial Statements Revance Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
479 M | 2.52 B | 900 M | 1.48 B | 970 M | 638 M | 1.03 B | 540 M | 505 M | 312 M | - | - | - |
Shares |
84.6 M | 72.7 M | 67.5 M | 58 M | 43.5 M | 36.2 M | 30.1 M | 28.1 M | 24.3 M | 19.4 M | - | - | - |
Historical Prices |
5.66 | 34.6 | 13.3 | 25.4 | 22.4 | 17.3 | 32.3 | 20 | 20.7 | 16.1 | - | - | - |
Net Income |
-324 M | -356 M | -281 M | -282 M | -159 M | -143 M | -121 M | -89.3 M | -73.5 M | -62.9 M | -52.4 M | -58.3 M | -44.9 M |
Revenue |
234 M | 133 M | 77.8 M | 15.3 M | 413 K | 3.73 M | 262 K | 300 K | 300 K | 383 K | 617 K | 717 K | 557 K |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | 617 K | 717 K | 552 K |
Operating Income |
-317 M | -342 M | -275 M | -273 M | -164 M | -143 M | -120 M | -88.2 M | -72.3 M | -52 M | -38.2 M | -43.2 M | - |
Interest Expense |
19.4 M | 16.5 M | 6.27 M | 15.1 M | - | 44 K | 457 K | 1.08 M | 1.19 M | 10.7 M | 15.2 M | 29 M | - |
EBITDA |
-305 M | -308 M | -255 M | -263 M | -162 M | -141 M | -116 M | -77.7 M | -70.3 M | -50 M | -36.3 M | -41.4 M | -25.8 M |
Operating Expenses |
- | - | - | - | 165 M | 146 M | 118 M | 79.5 M | 72.6 M | 52.4 M | 38.8 M | 43.9 M | 28.3 M |
General and Administrative Expenses |
298 M | 224 M | 199 M | 152 M | 62 M | 53.9 M | 37.4 M | 29.1 M | 25.1 M | 19 M | - | - | - |
All numbers in USD currency
Quarterly Income Statement Revance Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
104 M | 104 M | 91.9 M | 88 M | 86.6 M | 83.7 M | 81.1 M | 82.4 M | 72.2 M | 70.1 M | 68.3 M | 71.6 M | 67.8 M | 67.5 M | 66.6 M | 69.2 M | 60.5 M | 54.3 M | 53.9 M | 52.4 M | 43.3 M | 43.3 M | 41.6 M | 37 M | 36.3 M | 36.1 M | 36 M | 36.5 M | 30.3 M | 29.8 M | 28.8 M | 28.6 M | 28.2 M | 28.1 M | 28 M | 28.3 M | 23.8 M | 23.6 M | 23.5 M | 23.8 M | 23.3 M | 19.4 M | 11.1 M | 261 K | 229 K | 209 K | 204 K | - | - | - | - | - | - | - | - |
Net Income |
-38.1 M | -37.5 M | -53.2 M | - | -141 M | -67.3 M | -59.8 M | - | -84.7 M | -61.4 M | -64.3 M | - | -74.4 M | -72.2 M | -71.6 M | - | -81.3 M | -60.6 M | -61.9 M | -45.3 M | -41.4 M | -37.4 M | -35.3 M | -40.6 M | -32.8 M | -34.1 M | -35 M | -40.6 M | -30.7 M | -26.9 M | -27.2 M | -26.8 M | -18 M | -24.6 M | -19.9 M | -22.1 M | -19.2 M | -16.8 M | -15.4 M | -14.2 M | -14 M | -13.3 M | -21.4 M | -10.1 M | -8.88 M | -11.8 M | -52.4 M | - | - | - | - | - | - | - | - |
Revenue |
59.9 M | 65.4 M | 51.9 M | - | 54.1 M | 54.4 M | 45.8 M | - | 29 M | 28.4 M | 25.3 M | - | 19.7 M | 18.8 M | 13.3 M | - | 3.84 M | 299 K | 58 K | 89 K | 46 K | - | 278 K | 487 K | 2.36 M | 686 K | 193 K | 37 K | 75 K | 75 K | 75 K | 75 K | 75 K | 75 K | 75 K | 75 K | 75 K | 75 K | 75 K | 75 K | 75 K | 75 K | 158 K | 309 K | 158 K | 75 K | 75 K | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 21 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 158 K | - | - | - | 75 K | - | - | - | - | - | - | - | - |
Operating Income |
-32.3 M | -34.5 M | -46.8 M | - | -37.6 M | -56.3 M | -46.7 M | - | -77.5 M | -57.8 M | -62.2 M | - | -72.7 M | -70.3 M | -70 M | - | -77.1 M | -57.1 M | -61 M | -46.2 M | -42.5 M | -39.1 M | -36.6 M | -38.4 M | -33.6 M | -34.9 M | -35.7 M | - | -30.7 M | -26.8 M | -27.1 M | - | -17.7 M | -24.1 M | -19.7 M | - | -18.8 M | -16.6 M | -15.2 M | - | -13.8 M | -12.9 M | -11.5 M | - | -8.27 M | -11.3 M | -9.68 M | - | - | - | - | - | - | - | - |
Interest Expense |
-258 K | -453 K | 5.26 M | - | -223 K | -599 K | 4.5 M | - | 6.92 M | 3.87 M | 1.93 M | - | 1.57 M | 1.57 M | 1.56 M | - | 4.33 M | 4.26 M | 2.15 M | - | - | - | - | - | - | - | 44 K | - | 104 K | 141 K | 193 K | - | 256 K | 286 K | 315 K | - | 390 K | 279 K | 165 K | - | 228 K | 267 K | 9.84 M | - | 351 K | 490 K | 12.6 M | - | - | - | - | - | - | - | - |
EBITDA |
-31.7 M | -34 M | -44.8 M | - | -37.2 M | -55.6 M | -42.4 M | - | -73.6 M | -53.9 M | -56.8 M | - | -58.3 M | -61.1 M | -65.8 M | - | -71.2 M | -55 M | -60.2 M | -46.2 M | -40.4 M | -37.7 M | -36 M | -38.4 M | -32.4 M | -34.1 M | -35.3 M | - | -29.6 M | -26.1 M | -26.7 M | - | -16.7 M | -23.4 M | -19.4 M | - | -17.2 M | -15.5 M | -14.6 M | - | -13.2 M | -12.4 M | -11 M | - | -7.87 M | -10.9 M | -9.22 M | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 61 M | - | 42.6 M | 39.1 M | 36.9 M | - | 36 M | 35.6 M | 35.9 M | - | 30.8 M | 26.9 M | 27.2 M | - | 17.8 M | 24.2 M | 19.8 M | - | 18.8 M | 16.7 M | 15.2 M | - | 13.9 M | 13 M | 11.6 M | - | 8.43 M | 11.4 M | 9.75 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
62.6 M | 65.8 M | 68.9 M | - | 65.8 M | 74.8 M | 61.9 M | - | 65.8 M | 47.8 M | 45.1 M | - | 52.8 M | 50.6 M | 49 M | - | 48.2 M | 29.6 M | 21.2 M | - | 16.7 M | 13.6 M | 12.9 M | - | 14.2 M | 12.7 M | 13.6 M | - | 9.15 M | 8.61 M | 7.75 M | - | 7.5 M | 7.02 M | 7.46 M | - | 5.83 M | 6.36 M | 6 M | - | 5.3 M | 4.86 M | 4.09 M | - | 2.14 M | 3.64 M | 2.22 M | - | - | - | - | - | - | - | - |
All numbers in USD currency